Restricted access and advanced disease in post-pandemic testicular cancer
CONCLUSIONS: There was a 16.8% rise in clinical stage III disease from the pre-pandemic to post-pandemic period. Our study failed to identify a statistically significant increase in metastatic testis cancer incidence upon lifting of pandemic restrictions. Further study is necessary to confirm suspicions that pandemic restrictions contributed to increased incidence of metastatic testis cancer.PMID:38587978 | DOI:10.5489/cuaj.8648
Source: Canadian Urological Association Journal - Category: Urology & Nephrology Authors: Mitchell Fagan W C Ian Janes Matthew Andrews David R Harvey Geoff M Warden Michael K Organ Paul Johnston Source Type: research
More News: Canada Health | Cancer | Cancer & Oncology | COVID-19 | Germ Cell Tumors | International Medicine & Public Health | Pandemics | Primary Care | SARS | Statistics | Study | Testicular Cancer | Urology & Nephrology